MM
Highly rated in
29
conditions
Highly rated in
29
conditions
Check Dr. Maciej M. Mrugala's experience treating your condition:
About Dr. Maciej M. Mrugala

Maciej Mrugala is a Neurologist and an Oncologist in Scottsdale, Arizona. Mrugala has been practicing medicine for over 28 years and is highly rated in 29 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery. He is licensed to treat patients in Washington, Massachusetts, and Arizona. Mrugala is currently accepting new patients.

His clinical research consists of co-authoring 83 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Maciej M. Mrugala it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Maciej M. Mrugala accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
13400 E Shea Blvd, Scottsdale, AZ 85259
Background & Education
Graduate Institution
Other, 1995
Specialties
Neurology
Oncology
Licenses
Internal Medicine in AZ
Hospital Affiliations
Mayo Clinic Hospital - Arizona
Languages Spoken
English
Polish
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Safety and Efficacy Study of Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics and Anti-Tumor Activity of WSD0922-FUFU
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)
A Phase 1/2 Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Glioma
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors